Patents by Inventor John Duncia

John Duncia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CYCLIC DERIVATIVES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
    Publication number: 20080114052
    Abstract: The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma, processes for preparing and intermediates thereof.
    Type: Application
    Filed: January 23, 2008
    Publication date: May 15, 2008
    Inventors: Robert Cherney, Percy Carter, John Duncia, Daniel Gardner, Joseph Santella
  • HETEROCYCLIC PIPERIDINES AS MODULATORS OF CHEMOKINE RECEPTOR ACTIVITY
    Publication number: 20070299057
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Application
    Filed: March 25, 2004
    Publication date: December 27, 2007
    Inventors: Soo Ko, George Delucca, John Duncia, Joseph Santella, Dean Wacker
  • Cyclic derivatives as modulators of chemokine receptor activity
    Publication number: 20070032526
    Abstract: The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.
    Type: Application
    Filed: October 10, 2006
    Publication date: February 8, 2007
    Inventors: Peroy Carter, Robert Cherney, Douglas Batt, John Duncia, Daniel Gardner, Soo Ko, Anurag Srivastava, Michael Yang
  • Cyclic derivatives as modulators of chemokine receptor activity
    Publication number: 20070032541
    Abstract: The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma, processes for preparing and intermediates thereof.
    Type: Application
    Filed: October 10, 2006
    Publication date: February 8, 2007
    Inventors: Robert Cherney, Percy Carter, John Duncia, Daniel Gardner, Joseph Santella
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20060069128
    Abstract: The present application describes N-ureidoalkyl piperidines as modulators of chemokine receptors, or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Application
    Filed: October 24, 2005
    Publication date: March 30, 2006
    Inventors: John Duncia, Daniel Gardner, Joseph Santella
  • Bicyclic and tricyclic amines as modulators of chemokine receptor activity
    Publication number: 20060014964
    Abstract: The present application describes modulators of CCR3 of formula (I): A-E-NR1-G??(I) or pharmaceutically acceptable salt forms thereof, useful for the prevention of inflammatory diseases such as asthma and other allergic diseases.
    Type: Application
    Filed: September 13, 2005
    Publication date: January 19, 2006
    Inventors: John Duncia, Joseph Santella, Daniel Gardner, Dean Wacker
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20050192291
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Application
    Filed: December 23, 2004
    Publication date: September 1, 2005
    Inventors: Soo Ko, Cheryl Clark, George Delucca, John Duncia, Joseph Santella, Dean Wacker
  • N-ureidoalkyl-amino compounds as modulators of chemokine receptor activity
    Publication number: 20050153970
    Abstract: The present application describes modulators of chemokine receptors of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Application
    Filed: November 12, 2004
    Publication date: July 14, 2005
    Inventors: Soo Ko, Douglas Batt, George Delucca, John Duncia, Daniel Gardner, Joseph Santella
  • Benzylcycloalkyl amines as modulators of chemokine receptor activity
    Publication number: 20050124671
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of inflammatory diseases such as asthma and other allergic diseases.
    Type: Application
    Filed: January 21, 2005
    Publication date: June 9, 2005
    Inventors: Dean Wacker, John Duncia, Joseph Santella, Daniel Gardner
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Patent number: 6897234
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Grant
    Filed: June 26, 2002
    Date of Patent: May 24, 2005
    Assignee: Bristol-Myers Squibb Pharma Company
    Inventors: Soo Ko, George DeLucca, John Duncia, Ui Tae Kim, Joseph B. Santella III, Dean A. Wacker
  • N-ureidoalkyl-piperidines as modulators of chemokine receptor activity
    Publication number: 20050096325
    Abstract: The present application describes modulators of CCR3 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma and other allergic diseases.
    Type: Application
    Filed: November 8, 2004
    Publication date: May 5, 2005
    Inventors: Soo Ko, George DeLucca, John Duncia, Ui Kim, Joseph Santella, Dean Wacker
  • Cyclic derivatives as modulators of chemokine receptor activity
    Publication number: 20050054627
    Abstract: The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the treatment of rheumatoid arthritis, multiple sclerosis, atherosclerosis and asthma.
    Type: Application
    Filed: August 19, 2004
    Publication date: March 10, 2005
    Inventors: Percy Carter, Robert Cherney, Douglas Batt, John Duncia, Daniel Gardner, Soo Ko, Anurag Srivastava, Michael Yang
  • Substituted cycloalkylamine derivatives as modulators of chemokine receptor activity
    Publication number: 20050054626
    Abstract: The present application describes modulators of MCP-1 of formula (I): or pharmaceutically acceptable salt forms thereof, useful for the prevention of asthma, multiple sclerosis, artherosclerosis, and rheumatoid arthritis.
    Type: Application
    Filed: August 19, 2004
    Publication date: March 10, 2005
    Inventors: Percy Carter, Robert Cherney, Douglas Batt, Gregory Brown, John Duncia, Daniel Gardner, Michael Yang